InsidersTradesSigma
Follow the BEONE MEDICINES LTD stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €41.5bn. The latest transaction was reported on 8 September 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOHN V OYLER. All data is openly available.
Analysts rate BEONE MEDICINES LTD Strong Buy (bullish), based on 28 analysts. Average price target: US$432.16.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
BEONE MEDICINES LTD 是一家专注于开发创新医疗疗法的公司。该公司在纳斯达克上市。